ATRC
Price
$34.73
Change
+$0.73 (+2.15%)
Updated
Jun 3 closing price
Capitalization
1.45B
62 days until earnings call
NSPR
Price
$2.55
Change
+$0.01 (+0.39%)
Updated
Jun 3 closing price
Capitalization
55.59M
69 days until earnings call
Interact to see
Advertisement

ATRC vs NSPR

Header iconATRC vs NSPR Comparison
Open Charts ATRC vs NSPRBanner chart's image
AtriCure
Price$34.73
Change+$0.73 (+2.15%)
Volume$511.01K
Capitalization1.45B
InspireMD
Price$2.55
Change+$0.01 (+0.39%)
Volume$15.88K
Capitalization55.59M
ATRC vs NSPR Comparison Chart
Loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRC vs. NSPR commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a StrongBuy and NSPR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ATRC: $34.73 vs. NSPR: $2.55)
Brand notoriety: ATRC and NSPR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATRC: 83% vs. NSPR: 37%
Market capitalization -- ATRC: $1.45B vs. NSPR: $55.59M
ATRC [@Medical Specialties] is valued at $1.45B. NSPR’s [@Medical Specialties] market capitalization is $55.59M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 0 FA rating(s) are green whileNSPR’s FA Score has 0 green FA rating(s).

  • ATRC’s FA Score: 0 green, 5 red.
  • NSPR’s FA Score: 0 green, 5 red.
According to our system of comparison, NSPR is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 5 TA indicator(s) are bullish while NSPR’s TA Score has 6 bullish TA indicator(s).

  • ATRC’s TA Score: 5 bullish, 4 bearish.
  • NSPR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NSPR is a better buy in the short-term than ATRC.

Price Growth

ATRC (@Medical Specialties) experienced а +2.18% price change this week, while NSPR (@Medical Specialties) price change was +2.41% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.85%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +0.89%.

Reported Earning Dates

ATRC is expected to report earnings on Aug 05, 2025.

NSPR is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+0.85% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATRC($1.45B) has a higher market cap than NSPR($55.6M). ATRC YTD gains are higher at: 13.645 vs. NSPR (-3.042). ATRC has higher annual earnings (EBITDA): -8.11M vs. NSPR (-20.91M). ATRC has more cash in the bank: 137M vs. NSPR (39M). NSPR has less debt than ATRC: NSPR (1.6M) vs ATRC (74.5M). ATRC has higher revenues than NSPR: ATRC (399M) vs NSPR (6.21M).
ATRCNSPRATRC / NSPR
Capitalization1.45B55.6M2,604%
EBITDA-8.11M-20.91M39%
Gain YTD13.645-3.042-449%
P/E Ratio36.76N/A-
Revenue399M6.21M6,430%
Total Cash137M39M351%
Total Debt74.5M1.6M4,671%
FUNDAMENTALS RATINGS
ATRC vs NSPR: Fundamental Ratings
ATRC
NSPR
OUTLOOK RATING
1..100
7259
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4561
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
2150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NSPR's Valuation (38) in the Medical Specialties industry is in the same range as ATRC (70). This means that NSPR’s stock grew similarly to ATRC’s over the last 12 months.

NSPR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ATRC (100). This means that NSPR’s stock grew similarly to ATRC’s over the last 12 months.

NSPR's SMR Rating (100) in the Medical Specialties industry is in the same range as ATRC (100). This means that NSPR’s stock grew similarly to ATRC’s over the last 12 months.

ATRC's Price Growth Rating (45) in the Medical Specialties industry is in the same range as NSPR (61). This means that ATRC’s stock grew similarly to NSPR’s over the last 12 months.

ATRC's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as NSPR (100). This means that ATRC’s stock grew similarly to NSPR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCNSPR
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
Bearish Trend 13 days ago
84%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INTC20.290.74
+3.79%
Intel Corp
SHBI14.550.11
+0.76%
Shore Bancshares
CNTX0.58-0.01
-1.02%
Context Therapeutics
DAC84.21-1.22
-1.43%
Danaos Corp
SFM175.21-4.32
-2.41%
Sprouts Farmers Market